Injective, known for its protocol offerings in the
crypto space, put forth an
Exchange-Traded Fund (ETF) proposal now in the final public comment phase at the
SEC. Experts give varied
price predictions for the Injective Price (INJ), with some envisioning it hitting $50 in due time. The platform continues to expand, taking significant steps to include tokenized gold in 24/7 markets and launching their own
Native Ethereum Virtual Machine (EVM) aiming at a faster, more economical DeFi sector, rising potential for widespread adoption.
Pineapple Financial marks the first corporate treasury with a $100M investment for INJ.
Injective community and governance members passed key votes leading towards a significant reduction in INJ's supply, a move termed 'Supply Squeeze Tokenomics Shift', poised to positively impact INJ's price. From a technological perspective, Injective also premiered a no-code platform designed to ease
Web3 development. Besides these, Injective is making strides in the ETF space with increasing filings signaling growing demand for an altcoin fund and introducing the Staked Injective ETF by Canary Capital. Institutional involvement hiked with the launch of the Injective Treasury and strategic investments. Significant updates are in line for the network, resulting in Binance temporarily suspending INJ dealings. Despite these activities, INJ experienced a significant price drop in the last month. However, innovative measures and healthy governance votes all indicate an optimistic
outlook for INJ.
Injective Coin News Analytics from Wed, 21 Oct 2020 09:46:27 GMT to Fri, 30 Jan 2026 15:30:13 GMT -
Rating 6
- Innovation 8
- Information 9
- Rumor 6
